A tetrahydropiperine-cyclodextrin inclusion composition and its preparation method and application
Through the tetrahydropiperine-cyclodextrin inclusion composition, the hydrophobic properties of cyclodextrin are used to wrap tetrahydropiperine, which solves the problem of irritating reactions in cosmetics, and achieves high-efficiency and safety Skin care effects.
Patent Information
- Application Number
- CN202410242758.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-04
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-03-04
AI Technical Summary
Although tetrahydropiperine, as a penetrating agent, can effectively improve the skin's absorption of active ingredients in cosmetics, it may lead to irritating reactions when it comes into contact with the skin directly, such as redness, swelling, itching, etc., affecting safety.
Using tetrahydropiperine-cyclodextrin inclusion composition, tetrahydropiperine is encapsulated through the hydrophobic bonding part of cyclodextrin to form a stable molecular assembly system, improve the hydrophilicity and water solubility of the inclusion molecules, and reduce their tolerance. Skin irritation while maintaining a prone to osmotic effect.
While maintaining a strong pronunciation effect, it significantly reduces the irritation of tetrahydropiperine to the skin, reduces the occurrence of redness, swelling, itching, etc., and improves the safety and soothing effect of cosmetics.
Smart Images

Figure CN117919121B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of cosmetics, and in particular to a tetrahydropiperine-cyclodextrin inclusion composition and a preparation method and application thereof. Background Art
[0002] With the improvement of people's living standards and the acceleration of the pace of life and work, skin problems continue to emerge, and people pay more and more attention to skin care. Cosmetics have become a daily necessity for most consumers. The skin is a natural barrier between the human body and the outside world. It naturally has a certain degree of rejection and resistance to foreign substances. Therefore, how to effectively deliver the active ingredients of cosmetics to the skin is a key factor in their effectiveness.
[0003] The thickness of healthy human skin is about 0.5 to 4 mm, and the surface pH is between 4.4 and 7.0. It is divided into epidermis, dermis and subcutaneous tissue; the epidermis is a cell-rich layer, mainly composed of keratinocytes, which are the most numerous cell type and ultimately form a protective skin barrier to the external environment. Cosmetic efficacy substances usually produce effects through the skin through capillaries at a certain rate. At present, the transdermal absorption of cosmetic active substances is often limited by the extremely low permeability of active ingredients. This low permeability is mainly attributed to the stratum corneum of the skin, where the epidermal cell membrane is very tight. However, when the skin barrier is broken due to the abuse of penetration enhancers, it will lead to skin diseases and even systemic diseases. Based on this, the development of effective, safe and skin-friendly cosmetic penetration enhancers has gradually become one of the research hotspots in the cosmetics field.
[0004] Tetrahydropiperine is extracted from black pepper and is one of the few plant-derived penetration enhancers. In traditional applications, pepper is usually used as a seasoning and spice. With the advancement of science and technology, black pepper extract (tetrahydropiperine) has been found to enhance the permeability of cosmetic functional raw materials. It has the function of helping to promote the penetration and absorption of the required active ingredients in the skin and tissues. Compared with traditional penetration enhancers, tetrahydropiperine is particularly outstanding in its advantages of being all-natural, safe, small in quantity and high in efficiency, and is therefore widely used in the pharmaceutical and cosmetic industries. A very small amount of tetrahydropiperine (0.01-0.1wt%) can effectively promote the absorption and utilization of active ingredients by the skin. However, at the same time, direct contact of tetrahydropiperine with the skin may cause certain irritation to the skin, manifested as adverse reactions such as redness, swelling, itching, and fever. Therefore, how to improve the safety of its use has become one of the main issues in its research.
[0005] In order to effectively solve the above problems, the present invention provides a tetrahydropiperine-cyclodextrin inclusion composition, which can improve its penetration-promoting effect while effectively reducing its irritation to the skin, so that it can be widely used in various skin care products. Summary of the invention
[0006] In order to solve the above problems, the first aspect of the present invention provides a tetrahydropiperine-cyclodextrin inclusion composition, comprising tetrahydropiperine and cyclodextrin.
[0007] As a preferred solution, the mass ratio of tetrahydropiperine to cyclodextrin is (0.5-2):(3-7).
[0008] As a preferred solution, the mass ratio of tetrahydropiperine to cyclodextrin is (0.8-1.4):(4-6).
[0009] As a preferred solution, the mass ratio of tetrahydropiperine to cyclodextrin is 1:5.
[0010] As a preferred embodiment, the cyclodextrin is at least one of β-cyclodextrin, γ-cyclodextrin, α-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin.
[0011] As a preferred embodiment, the cyclodextrin is any one of β-cyclodextrin, γ-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin.
[0012] As a preferred embodiment, the cyclodextrin is 2-hydroxypropyl-β-cyclodextrin.
[0013] The second aspect of the present invention provides a method for preparing the above-mentioned tetrahydropiperine-cyclodextrin inclusion composition, and the preparation method comprises the following steps: S1: adding cyclodextrin to ultrapure water and heating it to 25-90°C for 1-20 hours until it is completely dissolved, then adding an organic solution containing tetrahydropiperine to mix, and keeping the mixture warm and stirring at a speed of 200-1000 rpm for 5-15 hours; S2: concentrating the obtained material suspension by a rotary evaporator to remove the solvent, and obtaining the tetrahydropiperine-cyclodextrin inclusion composition after drying and washing.
[0014] As a preferred solution, the organic solvent in the organic solution of tetrahydropiperine is at least one of methanol, ethanol, N,N-dimethylformamide, acetone, glycerol, butanediol and toluene.
[0015] As a preferred solution, the organic solvent in the organic solution of tetrahydropiperine is methanol or ethanol.
[0016] As a preferred solution, the usage ratio of cyclodextrin to ultrapure water is 80-150 g: 200-400 mL.
[0017] As a preferred solution, the usage ratio of the cyclodextrin to ultrapure water is 100-120 g: 250-350 mL.
[0018] As a preferred solution, the usage ratio of cyclodextrin to ultrapure water is 100g:250-280mL.
[0019] As a preferred solution, the usage ratio of tetrahydropiperine to the organic solvent is 1-30 g:100-300 mL.
[0020] As a preferred solution, the usage ratio of tetrahydropiperine to the organic solvent is 5-25 g:100-250 mL.
[0021] As a preferred solution, the usage ratio of tetrahydropiperine to the organic solvent is 10-20 g:100-200 mL.
[0022] As a preferred solution, the usage ratio of tetrahydropiperine to the organic solvent is 20g:100mL.
[0023] As a preferred solution, the drying is heating vacuum drying or freeze drying.
[0024] As a preferred solution, the heating vacuum drying step is: heating the material after the solvent is removed to 70-90° C., and drying it in a vacuum environment for 8-14 hours to obtain a vacuum-dried white powder.
[0025] As a preferred solution, the freeze-drying step is: pre-freeze the material after removing the solvent at -80 to 0°C for 20 to 30 hours, and then freeze-dry it at -40 to -4°C for 24 to 72 hours to obtain a freeze-dried white powder.
[0026] In the present invention, the prepared tetrahydropiperine-cyclodextrin inclusion composition can avoid the irritation of tetrahydropiperine to the skin while maintaining a very strong penetration-promoting effect, thereby reducing the phenomenon of causing problems such as skin redness, swelling, and itching. The inclusion technical solution adopted in the present invention can make full use of the hydrophilicity of the outer edge and the hydrophobicity of the inner cavity of cyclodextrin, and then effectively encapsulate the tetrahydropiperine through the hydrophobic binding part, thereby forming a stable matching molecular assembly system, while greatly improving the hydrophilicity and water solubility of the inclusion molecule, reducing the direct irritation of the tetrahydropiperine molecule to the skin without affecting its own efficacy, thereby avoiding inflammation, itching and other problems.
[0027] The third aspect of the present invention provides an application of the above-mentioned tetrahydropiperine-cyclodextrin inclusion composition, including application of the tetrahydropiperine-cyclodextrin inclusion composition in facial mask products, creams, emulsions, essences, and aqueous cosmetics.
[0028] As a preferred solution, the total content of the tetrahydropiperine-cyclodextrin inclusion composition in the cosmetic is 0.1-5 wt %.
[0029] As a preferred solution, the total content of the tetrahydropiperine-cyclodextrin inclusion composition in the cosmetic is 0.1-1 wt %.
[0030] As a preferred solution, the essence comprises, by mass percentage, the following raw materials: 2-3% glycerol, 3-4% butylene glycol, 0.3-0.5% p-hydroxyacetophenone, 0.4-0.6% hexylene glycol, 0.1-0.2% sodium acrylate copolymer, 0.1-0.2% lecithin, 2-3% niacinamide, 0.5-1% squalane, 0.5-1% xanthan gum, 1-2% diethoxyethyl succinate, 0.3-0.8% jojoba seed oil, 0.1-0.3% glyceryl stearate, 0.05-0.15% PEG-100 stearate, 0.04-0.06% EDTA-2Na, 0.1-5% tetrahydropiperine-cyclodextrin inclusion composition, 0.5-2% polypeptide, 1-5% plant extract, and the balance is supplemented by water.
[0031] As a preferred embodiment, the polypeptide includes dipeptide-1, acetyl tetrapeptide-9 and palmitoyl tripeptide-8.
[0032] As a preferred solution, the mass ratio of the dipeptide-1, acetyl tetrapeptide-9 and palmitoyl tripeptide-8 is (3-5): (0.5-1): (1-2).
[0033] As a preferred solution, the mass ratio of the dipeptide-1, acetyl tetrapeptide-9 and palmitoyl tripeptide-8 is 4:0.8:1.2.
[0034] As a preferred embodiment, the plant extract is at least one of turmeric root extract, withania somnifera extract, anthemis nobilis extract, Centella asiatica extract, aloe vera extract, sophora flavescens root extract, witch hazel extract, Poria cocos sclerotium extract, violet extract, apple extract, sea buckthorn fruit extract, saffron extract, peony extract, green mandarin extract, lavender extract, and horse chestnut extract.
[0035] As a preferred solution, the plant extract includes saffron extract, turmeric root extract and peony extract. Further preferably, the mass ratio of the turmeric root extract to the peony extract is (0.5-1): (2-3), and the cosmetic soothing effect obtained by this ratio is more excellent.
[0036] As a preferred solution, the mass ratio of the turmeric root extract to the peony extract is 0.8:2.2.
[0037] The combination of the above-mentioned polypeptides used in the present invention can effectively stop inflammation of the skin, and effectively repair and remove redness, and significantly enhance the skin soothing and repairing function of the composition. When the mass ratio of dipeptide-1, acetyl tetrapeptide-9 and palmitoyl tripeptide-8 is (3-5): (0.5-1): (1-2), the interaction between the three can synergistically activate and stimulate each other's functional activity. On the other hand, when the composition reaches the skin diseased area, dipeptide-1 can effectively inhibit the release of inflammatory factors and reduce the redness and swelling caused by excessive expansion of blood vessels. With the addition of palmitoyl tripeptide-8, the activity of dipeptide-1 and acetyl tetrapeptide-9 for superoxide dismutase and catalase can be activated, thereby removing free radical groups on the skin surface and promoting collagen synthesis, thereby greatly enhancing the soothing effect.
[0038] As a preferred solution, the preparation method of the essence comprises the following steps: S1: mixing glycerol, p-hydroxyacetophenone, hexylene glycol, butylene glycol, xanthan gum, EDTA-2Na, sodium acrylate copolymer, lecithin, diethoxyethyl succinate and water to obtain a mixture A; S2: mixing jojoba seed oil, squalane, glyceryl stearate and PEG-100 stearate to obtain a mixture B; S3: mixing niacinamide, polypeptide, plant extract, tetrahydropiperine-cyclodextrin inclusion composition to obtain a mixture C; S4: heating the mixture A and the mixture B to 80-85°C, homogenizing and mixing, cooling to 40-50°C, and adding the mixture C to obtain the essence.
[0039] The present invention has the beneficial effects:
[0040] 1. The present invention provides a tetrahydropiperine-cyclodextrin inclusion composition, which can improve its penetration-promoting effect while effectively reducing its irritation to the skin, effectively avoiding the irritation to the skin when tetrahydropiperine is used alone, as well as the subsequent inflammation, redness and itching problems, so that it can be widely used in a variety of skin care products, and has an excellent soothing effect.
[0041] 2. The present invention provides a tetrahydropiperine-cyclodextrin inclusion composition. The prepared tetrahydropiperine-cyclodextrin inclusion composition can avoid the irritation of tetrahydropiperine to the skin while maintaining a very strong penetration-promoting effect, thereby reducing the induction of skin redness, swelling, itching and other problems. The composition can fully utilize the hydrophilicity of the outer edge and the hydrophobicity of the inner cavity of cyclodextrin, and then effectively encapsulate tetrahydropiperine through the hydrophobic binding part, thereby forming a stable matching molecular assembly system. While greatly improving the hydrophilicity and water solubility of the inclusion molecule, the direct irritation of the tetrahydropiperine molecule to the skin is reduced without affecting its own efficacy.
[0042] 3. The present invention provides a tetrahydropiperine-cyclodextrin inclusion composition, which has a simple preparation method, simple and easily available raw materials, and no obvious corrosive reaction to production equipment, which can greatly ensure the production cost of the composition and reduce the equipment maintenance cost.
[0043] 4. The present invention provides an essence comprising a tetrahydropiperine-cyclodextrin inclusion composition. The combination of the above-mentioned polypeptides can effectively stop inflammation and damage to the skin, and effectively repair and remove redness, and significantly improve the skin soothing and repairing function of the composition. When the mass ratio of dipeptide-1, acetyl tetrapeptide-9 and palmitoyl tripeptide-8 is (3-5): (0.5-1): (1-2), the interaction between the three can synergistically activate and stimulate each other's functional activity. On the other hand, when the composition reaches the skin diseased area, dipeptide-1 can effectively inhibit the release of inflammatory factors and reduce the redness and swelling caused by excessive expansion of blood vessels. With the addition of palmitoyl tripeptide-8, the activity of dipeptide-1 and acetyl tetrapeptide-9 on superoxide dismutase and catalase can be activated, thereby removing free radical groups on the skin surface and promoting collagen synthesis, thereby greatly enhancing the soothing effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0044] Figure 1 is the nuclear magnetic resonance hydrogen spectrum of tetrahydropiperine in Example 1 of the present invention ( 1 H-NMR).
[0045] Figure 2 is the hydrogen nuclear magnetic resonance spectrum of 2-hydroxypropyl-β-cyclodextrin in Example 1 of the present invention ( 1 H-NMR).
[0046] Figure 3 This is the nuclear magnetic resonance hydrogen spectrum of the tetrahydropiperine-2-hydroxypropyl-β-cyclodextrin inclusion composition prepared in Example 1 of the present invention ( 1 H-NMR).
[0047] Figure 4 The nuclear magnetic resonance hydrogen spectrum of the physical mixture of tetrahydropiperine and 2-hydroxypropyl-β-cyclodextrin prepared in Comparative Example 1 of the present invention ( 1 H-NMR).
[0048] Figure 5 This is a graph showing the cytotoxicity effect of the tetrahydropiperine-2-hydroxypropyl-β-cyclodextrin inclusion composition prepared in Example 1 of the present invention on HaCat cells.
[0049] Figure 6 This is a graph showing the cytotoxicity effect of the tetrahydropiperine-2-hydroxypropyl-β-cyclodextrin inclusion composition prepared in Example 1 of the present invention on RAW264.7 cells. DETAILED DESCRIPTION
[0050] The technical solutions in the above-mentioned invention content of the present invention will be further described and demonstrated in the form of specific implementation schemes below. The following embodiments are only practical examples used to illustrate and explain the contents of the technical solutions in the specification and should not limit the scope of the claims to be protected by the present invention. All technical products based on the technical solutions described in the invention content of this application should be included in the scope to be protected by the present invention.
[0051] In the following examples, unless otherwise specified, the raw materials are all commercially available products, or can be prepared by methods well known to those skilled in the art.
[0052] Example 1
[0053] Embodiment 1 provides a tetrahydropiperine-cyclodextrin inclusion composition, comprising tetrahydropiperine and cyclodextrin; the preparation method comprises the following steps: S1: adding 100g of 2-hydroxypropyl-β-cyclodextrin to 270mL of ultrapure water and heating to 90°C, heating for 4h until completely dissolved, then adding 100mL of ethanol solution containing 20g of tetrahydropiperine to mix, and keeping warm and stirring at 600rpm for 12h; S2: concentrating the obtained material suspension to remove the solvent through a rotary evaporator, then naturally cooling to room temperature, and then precooling the solution in a -80°C environment for 24h, and then freeze-drying in a -20°C environment to obtain a freeze-dried white powder, that is, the tetrahydropiperine-cyclodextrin inclusion composition.
[0054] The nuclear magnetic resonance spectroscopy of this example is as follows:
[0055] 2-Hydroxypropyl-β-cyclodextrin 1 H NMR (400 MHz, D2O) δ 5.09, 4.95, 4.70, 3.90, 3.86, 3.83, 3.81, 3.74, 3.59, 3.53, 3.50, 3.46, 3.44, 3.38, 3.35, 1.03, 1.01. The hydrogen nuclear magnetic resonance spectrum of 2-hydroxypropyl-β-cyclodextrin is shown in Figure 1 .
[0056] Tetrahydropiperine 1 H NMR (400 MHz, DMSO) δ 6.80, 6.79, 6.77, 6.64, 6.62, 5.95, 3.41, 3.39, 3.38, 3.37, 3.35, 3.33, 2.52, 2.51, 2.50, 2.48, 2.29, 2.28, 2.26, 1.57, 1.56, 1.54, 1.53, 1.52, 1.50, 1.48, 1.46, 1.45, 1.39, 1.38. The hydrogen NMR spectrum of tetrahydropiperine is shown in Figure 2.
[0057] Tetrahydropiperine-2-hydroxypropyl-β-cyclodextrin inclusion composition 1 H NMR (400 MHz, DMSO) δ 6.78, 6.76, 6.74, 6.63, 6.61, 5.93, 5.77, 5.74, 5.72, 5.58, 5.02, 4.83, 4.55, 3.74, 3.62, 3.57, 3.45, 3.38, 3.33, 2.51, 2.48, 2.28, 2.26, 2.24, 1.55, 1.54, 1.52, 1.46, 1.44, 1.43, 1.39, 1.02. The H NMR spectrum of the tetrahydropiperine-2-hydroxypropyl-β-cyclodextrin inclusion compound is shown in Figure 3 .
[0058] Example 2
[0059] Embodiment 2 provides a tetrahydropiperine-cyclodextrin inclusion composition, comprising tetrahydropiperine and cyclodextrin; the preparation method comprises the following steps: S1: adding 100 g of β-cyclodextrin to 270 mL of ultrapure water and heating to 85° C., heating for 4 hours until completely dissolved, then slowly dropping 100 mL of ethanol solution containing 20 g of tetrahydropiperine into the β-cyclodextrin solution through a constant pressure dropping funnel within 1 hour, and keeping warm and stirring at a speed of 600 rpm for 12 hours; S2: concentrating the obtained material suspension through a rotary evaporator to remove the solvent, vacuum drying at 80° C. for 12 hours to obtain a white powder, washing the white powder with precooled ethanol, and obtaining the tetrahydropiperine-cyclodextrin inclusion composition after completion.
[0060] Example 3
[0061] Example 3 provides a tetrahydropiperine-cyclodextrin inclusion composition, comprising tetrahydropiperine and cyclodextrin; the preparation method comprises the following steps: S1: adding 100 g of γ-cyclodextrin to 270 mL of ultrapure water and heating to 45° C., heating for 8 hours until completely dissolved, then slowly dropping 100 mL of ethanol solution containing 20 g of tetrahydropiperine into the γ-cyclodextrin solution through a constant pressure dropping funnel within 1 hour, and keeping warm and stirring at 600 rpm for 12 hours; S2: concentrating the obtained material suspension to remove the solvent through a rotary evaporator, vacuum drying at 80° C. for 12 hours to obtain a white powder, washing the white powder with pre-cooled ethanol, and obtaining the tetrahydropiperine-cyclodextrin inclusion composition after completion.
[0062] Example 4
[0063] Embodiment 4 provides a tetrahydropiperine-cyclodextrin inclusion composition, comprising tetrahydropiperine and cyclodextrin; the preparation method comprises the following steps: S1: adding 100 g of α-cyclodextrin to 270 mL of ultrapure water and heating to 60° C., heating for 6 h until completely dissolved, then slowly dropping 100 mL of ethanol solution containing 20 g of tetrahydropiperine into the α-cyclodextrin solution through a constant pressure dropping funnel within 1 hour, and keeping the mixture warm and stirring at 600 rpm for 12 h; S2: concentrating the obtained material suspension to remove the solvent through a rotary evaporator, spray drying under nitrogen protection, controlling the inlet air temperature at 110° C., maintaining the injection speed at 12 mL / min, collecting the spray dried material, and obtaining the tetrahydropiperine-cyclodextrin inclusion composition after completion.
[0064] Example 5
[0065] Example 5 The first aspect provides an essence comprising the tetrahydropiperine-cyclodextrin inclusion composition prepared in Example 1, wherein the raw materials include, by mass percentage: 3% glycerol, 3% butylene glycol, 0.5% p-hydroxyacetophenone, 0.5% hexylene glycol, 0.1% sodium acrylate copolymer, 0.1% lecithin, 2% niacinamide, 0.5% squalane, 1% xanthan gum, 2% diethoxyethyl succinate, 0.8% jojoba seed oil, 0.3% glyceryl stearate, 0.1% PEG-100 stearate, 0.05% EDTA-2Na, 5% tetrahydropiperine-cyclodextrin inclusion composition, 1% polypeptide, 3% plant extract, and water as the balance.
[0066] The polypeptides are dipeptide-1, acetyl tetrapeptide-9 and palmitoyl tripeptide-8, with a mass ratio of 4:0.8:1.2.
[0067] The mass ratio of the plant extracts saffron extract, turmeric root extract and peony extract is 4:0.8:2.2.
[0068] Xanthan gum was purchased from edible and medical grade xanthan gum products sold by Shaanxi Yunsheng Biotechnology Co., Ltd.
[0069] Saffron extract was purchased from saffron extract products sold by Shaanxi Tianshengyuan Biotechnology Co., Ltd.; turmeric root extract was purchased from turmeric root extract products sold by Jiangsu Caiwei Biotechnology Co., Ltd.; peony extract was purchased from peony extract products sold by Xi'an Haoxuan Biotechnology Co., Ltd.
[0070] The second aspect of the present embodiment provides a method for preparing the above-mentioned essence, and the preparation method comprises the following steps: S1: mixing glycerol, p-hydroxyacetophenone, hexylene glycol, butylene glycol, xanthan gum, EDTA-2Na, sodium acrylate copolymer, lecithin, diethoxyethyl succinate and water to obtain a mixture A; S2: mixing jojoba seed oil, squalane, glyceryl stearate and PEG-100 stearate to obtain a mixture B; S3: mixing niacinamide, polypeptide, plant extract, tetrahydropiperine-cyclodextrin inclusion composition to obtain a mixture C; S4: heating the mixture A and the mixture B to 80°C and homogenizing, cooling to 45°C, and adding the mixture C to obtain the essence.
[0071] Comparative Example 1
[0072] This comparative example provides a tetrahydropiperine-cyclodextrin physical blend composition, and the preparation method is: physically mix tetrahydropiperine and cyclodextrin in a mass ratio of 1:5, and stir evenly to obtain the composition.
[0073] Comparative Example 2
[0074] The specific implementation of this comparative example is basically the same as that of Example 5, except that: the essence, in terms of mass percentage, comprises the following raw materials: 3% glycerol, 3% butylene glycol, 0.5% p-hydroxyacetophenone, 0.5% hexylene glycol, 0.1% sodium acrylate copolymer, 0.1% lecithin, 2% niacinamide, 0.5% squalane, 1% xanthan gum, 2% diethoxyethyl succinate, 0.8% jojoba seed oil, 0.3% glyceryl stearate, 0.1% PEG-100 stearate, 0.05% EDTA-2Na, 0.75% tetrahydropiperine, 1% polypeptide, 3% plant extract, and the balance is supplemented by water.
[0075] Comparative Example 3
[0076] The specific implementation of this comparative example is basically the same as that of Example 5, except that the polypeptides are dipeptide-1, acetyl tetrapeptide-9 and palmitoyl tripeptide-8, and the mass ratio is 6:0.2:0.4
[0077] Comparative Example 4
[0078] The specific implementation of this comparative example is basically the same as that of Example 5, except that the polypeptides are dipeptide-1, acetyl tetrapeptide-9 and palmitoyl tripeptide-8, and the mass ratio is 1:1.5:0.5.
[0079] Comparative Example 5
[0080] The specific implementation of this comparative example is basically the same as that of Example 5, except that the polypeptides are dipeptide-1, carnosine and nisin, and the mass ratio is 4:0.8:1.2.
[0081] Comparative Example 6
[0082] The specific implementation of this comparative example is basically the same as that of Example 5, except that the plant extracts are saffron extract, turmeric root extract and peony extract, with a mass ratio of 4:0.1:2.9.
[0083] Comparative Example 7
[0084] The specific implementation of this comparative example is basically the same as that of Example 5, except that the plant extracts are saffron extract, turmeric root extract and peony extract, with a mass ratio of 4:2.5:0.5.
[0085] Comparative Example 8
[0086] The specific implementation of this comparative example is basically the same as that of Example 5, except that the plant extracts are saffron extract and turmeric root extract in a mass ratio of 4:3.
[0087] Comparative Example 9
[0088] The specific implementation of this comparative example is basically the same as that of Example 5, except that the plant extracts are saffron extract and peony extract in a mass ratio of 4:3.
[0089] Performance Evaluation
[0090] 1. Cytotoxicity test:
[0091] The cytotoxicity of the tetrahydropiperine-cyclodextrin inclusion composition was tested by MTT method, and the cells used were human immortalized epidermal cells (HaCat cells) and mouse mononuclear macrophages (RAW264.7 cells).
[0092] Experimental method: HaCat cells or RAW264.7 cells growing in logarithmic phase were cultured at 1×10 4 Cells were plated in 96-well plates with 100 μL per well and incubated in a culture incubator for 24 h. The sample group was added with tetrahydropiperine-cyclodextrin inclusion compositions diluted with DMEM high-glucose medium to different mass concentrations. The culture incubator was continued for 48 h. Then, 10 μL of 5 mg / mL MTT solution was added and incubated for 4 h. The culture medium was removed and 100 μL of DMSO was added. The absorbance was measured at 490 nm using an enzyme reader, and the cell survival rate was calculated according to the formula; the cell survival rate formula is as follows:
[0093]
[0094] The results are as follows Figure 5 and Figure 6As shown, the tetrahydropiperine-cyclodextrin inclusion composition prepared in Example 1 has no obvious inhibitory effect on the survival rate of HaCat cells and RAW264.7 cells at a concentration of less than 10 mg / mL, and it can be considered that the inclusion composition is non-toxic or has extremely low toxicity.
[0095] 2. Water solubility test:
[0096] The water solubility test of the tetrahydropiperine-cyclodextrin inclusion composition prepared in Example 1 was carried out. At 20° C., 100 grams of water can completely dissolve 50 grams of tetrahydropiperine-2-hydroxypropyl-β-cyclodextrin inclusion composition containing 15% (mass fraction) of tetrahydropiperine, that is, the tetrahydropiperine contained in the solution reaches 7.5 grams. The solubility of tetrahydropiperine monomer in water under the same conditions is less than 0.1 grams, which proves that the solubility of the inclusion compound formed by the inclusion of tetrahydropiperine by cyclodextrin in water is greatly increased.
[0097] 3. Stability test:
[0098] The stability test was performed on the tetrahydropiperine-cyclodextrin inclusion composition prepared in Example 1. The stability of the tetrahydropiperine-2-hydroxypropyl-β-cyclodextrin inclusion composition and the tetrahydropiperine monomer was observed at a temperature of 45±2° C. and under light conditions, respectively. The specific results are shown in Table 1.
[0099] Table 1 Light stability test
[0100]
[0101] The results show that tetrahydropiperine will gradually change color after being placed under light and heat conditions for one month. In comparison, tetrahydropiperine encapsulated with 2-hydroxypropyl-β-cyclodextrin has better stability and does not change color after being placed under light and heat conditions for one month. It has a wider range of applications in cosmetics.
[0102] 4. Essence stability test:
[0103] The stability test was performed on the essences prepared in Example 5 and Comparative Example 2. Test method: 10 g of the essences of Example 5 and Comparative Example 2 were centrifuged at 3000 rpm for 30 minutes, and then subjected to stability tests such as light exposure, heating at 55°C, and freeze-thaw cycles for 1 month. The test results are shown in Table 2.
[0104] Table 2 Essence stability test
[0105]
[0106]
[0107] 5. Soothing effect test:
[0108] The essences prepared in Example 5 and Comparative Examples 2 to 9 were tested for their soothing efficacy.
[0109] Test method: Detect the inhibitory effect of the essence on TNF-α and IL-1α; the test model is keratinocytes; the test groups are divided into sample group, blank control group and negative control group.
[0110] Sample group: containing CAP culture medium (15 μM) and the essence prepared in Example 5 and Comparative Examples 2 to 9 at the same concentration; Blank control group: blank group without medication; Negative control group: CAP culture medium at a concentration of 15 μM.
[0111] Detection steps: keratinocytes were inoculated into 6-well plates and cultured completely, and the plating rate was ensured to be ≥40%. The cells were divided into groups and the dosage was 2 mL per well. After the administration, the cells were cultured in a CO2 incubator (37°C, 5% CO2) for 24 h. After the completion of the treatment, all the cells except the blank control group were irradiated with UVB at a dose of 300 mJ / cm. After the irradiation, the cells were cultured in a CO2 incubator (37°C, 5% CO2) for 24 h. The supernatant of the cell culture was collected and tested with an ELISA kit. The test was performed according to the instructions of the ELISA kit. The inhibition rate of TNF-α and IL-1α was calculated by the results. The inhibition rate (%) = (negative control group - sample group) / negative control group × 100%. The average value of the results was recorded in Table 3.
[0112] Table 3
[0113] Example TNF-α inhibition % IL-1α inhibition % Example 5 22.65 48.54 Comparative Example 2 18.43 38.36 Comparative Example 3 20.85 46.73 Comparative Example 4 21.02 45.82 Comparative Example 5 18.13 42.05 Comparative Example 6 21.45 47.27 Comparative Example 7 20.97 46.24 Comparative Example 8 19.14 43.31 Comparative Example 9 18.73 42.76
[0114] From the test results obtained in the examples and comparative examples, the inclusion composition and essence in the examples prepared by the special technical solution of the present invention can obtain excellent skin penetration promoting effect, thereby improving its soothing, anti-inflammatory and antipruritic effects on the skin, and improving the efficiency and quality of cosmetics in solving skin problems. However, since the comparative examples do not fully adopt the technical solution of the present invention, their corresponding technical effects are significantly worse than those of the above examples, which strongly proves that the technical effect of the technical solution adopted in the present invention is a non-obvious technical effect and can effectively solve the corresponding technical problems.
Claims
1. An application of a tetrahydropiperine-cyclodextrin inclusion composition in the preparation of an essence, characterized in that: The essence comprises, by mass percentage, 2-3% glycerol, 3-4% butylene glycol, 0.3-0.5% p-hydroxyacetophenone, 0.4-0.6% hexylene glycol, 0.1-0.2% sodium acrylate copolymer, 0.1-0.2% lecithin, 2-3% niacinamide, 0.5-1% squalane, 0.5-1% xanthan gum, 1-2% diethoxyethyl succinate, 0.3-0.8% jojoba seed oil, 0.1-0.3% glyceryl stearate, 0.05-0.15% PEG-100 stearate, 0.04-0.06% EDTA-2Na, 0.1-5% tetrahydropiperine-cyclodextrin inclusion composition, 0.5-2% polypeptide, 1-5% plant extract, and the balance is supplemented by water; The polypeptides are dipeptide-1, acetyl tetrapeptide-9 and palmitoyl tripeptide-8, with a mass ratio of (3~5):(0.5~1):(1~2); The plant extract comprises saffron extract, turmeric root extract and peony extract; the mass ratio of the turmeric root extract to the peony extract is (0.5-1): (2-3); The tetrahydropiperine-cyclodextrin inclusion composition comprises tetrahydropiperine and cyclodextrin; The mass ratio of tetrahydropiperine to cyclodextrin is (0.5-2): (3-7); The cyclodextrin is at least one of β-cyclodextrin, γ-cyclodextrin, α-cyclodextrin, and 2-hydroxypropyl-β-cyclodextrin; The preparation method of the tetrahydropiperine-cyclodextrin inclusion composition comprises the following steps: S1: adding cyclodextrin to ultrapure water and heating to 25-90°C for 1-20 hours until completely dissolved, then adding an organic solution containing tetrahydropiperine to mix, and keeping the mixture warm and stirring at a speed of 200-1000 rpm for 5-15 hours; S2: concentrating the obtained material suspension through a rotary evaporator to remove the solvent, and drying and washing to obtain the tetrahydropiperine-cyclodextrin inclusion composition.
2. The use according to claim 1, characterized in that: The organic solvent in the organic solution of tetrahydropiperine is at least one of methanol, ethanol, N,N-dimethylformamide, acetone, glycerol, butanediol and toluene.
3. The use according to claim 1, characterized in that: The usage ratio of the cyclodextrin to ultrapure water is 80-150 g: 200-400 mL.
4. The use according to claim 1, characterized in that: The dosage ratio of the tetrahydropiperine to the organic solvent is 1-30 g: 100-300 mL.
5. The use according to claim 1, characterized in that: The drying is heating vacuum drying or freeze drying; the heating vacuum drying step is: heating the material after the solvent is removed to 70-90°C, and drying it in a vacuum environment for 8-14 hours to obtain a vacuum-dried white powder; the freeze drying step is: pre-freezing the material after the solvent is removed at -80-0°C for 20-30 hours, and then freeze drying it at -40--4°C for 24-72 hours to obtain a freeze-dried white powder.
